Colgate-Palmolive (NYSE:CL) Shares Bought by Westwood Holdings Group Inc.

Share on StockTwits

Westwood Holdings Group Inc. increased its stake in Colgate-Palmolive (NYSE:CL) by 24.4% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,568,298 shares of the company’s stock after purchasing an additional 307,837 shares during the period. Colgate-Palmolive accounts for about 1.2% of Westwood Holdings Group Inc.’s portfolio, making the stock its 15th largest position. Westwood Holdings Group Inc. owned about 0.18% of Colgate-Palmolive worth $112,401,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in CL. Invesco Ltd. boosted its stake in Colgate-Palmolive by 201.8% in the 2nd quarter. Invesco Ltd. now owns 8,642,044 shares of the company’s stock worth $619,374,000 after purchasing an additional 5,778,145 shares in the last quarter. FMR LLC boosted its stake in Colgate-Palmolive by 29.1% in the 1st quarter. FMR LLC now owns 7,384,604 shares of the company’s stock worth $506,141,000 after purchasing an additional 1,665,348 shares in the last quarter. AQR Capital Management LLC boosted its stake in Colgate-Palmolive by 52.2% in the 2nd quarter. AQR Capital Management LLC now owns 3,485,442 shares of the company’s stock worth $249,801,000 after purchasing an additional 1,195,074 shares in the last quarter. Vanguard Group Inc. boosted its stake in Colgate-Palmolive by 1.4% in the 2nd quarter. Vanguard Group Inc. now owns 76,502,840 shares of the company’s stock worth $5,482,958,000 after purchasing an additional 1,056,530 shares in the last quarter. Finally, Natixis boosted its stake in Colgate-Palmolive by 504.3% in the 2nd quarter. Natixis now owns 1,009,727 shares of the company’s stock worth $72,367,000 after purchasing an additional 842,644 shares in the last quarter. Institutional investors own 75.94% of the company’s stock.

Several brokerages have commented on CL. Zacks Investment Research cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $77.00 price objective for the company. in a research note on Friday, June 7th. Citigroup lifted their price objective on shares of Colgate-Palmolive from $77.00 to $79.00 and gave the company a “neutral” rating in a research note on Tuesday, August 20th. Bank of America set a $80.00 price objective on shares of Colgate-Palmolive and gave the company a “buy” rating in a research note on Friday, July 12th. Morgan Stanley lifted their price objective on shares of Colgate-Palmolive from $72.00 to $74.00 and gave the company an “equal weight” rating in a research note on Monday, July 29th. Finally, ValuEngine cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and six have issued a buy rating to the stock. Colgate-Palmolive has an average rating of “Hold” and a consensus price target of $73.87.

Shares of NYSE:CL traded up $0.01 during trading on Friday, hitting $70.96. 94,665 shares of the stock traded hands, compared to its average volume of 2,811,776. The company has a quick ratio of 0.78, a current ratio of 1.13 and a debt-to-equity ratio of 32.25. The company has a market cap of $61.05 billion, a price-to-earnings ratio of 23.89, a P/E/G ratio of 4.50 and a beta of 0.75. The company has a fifty day moving average price of $72.24 and a two-hundred day moving average price of $70.98. Colgate-Palmolive has a 52-week low of $57.41 and a 52-week high of $76.41.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 26th. The company reported $0.72 earnings per share for the quarter, meeting the consensus estimate of $0.72. The firm had revenue of $3.87 billion during the quarter, compared to analyst estimates of $3.88 billion. Colgate-Palmolive had a net margin of 14.77% and a negative return on equity of 10,821.98%. The business’s quarterly revenue was down .5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.77 EPS. On average, equities research analysts predict that Colgate-Palmolive will post 2.84 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Wednesday, October 23rd will be issued a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 2.42%. The ex-dividend date is Tuesday, October 22nd. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.91%.

In related news, CFO Henning I. Jakobsen sold 858 shares of the business’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $74.60, for a total value of $64,006.80. Following the completion of the sale, the chief financial officer now owns 39,031 shares of the company’s stock, valued at approximately $2,911,712.60. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, VP Philip G. Shotts sold 407 shares of the business’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $74.60, for a total transaction of $30,362.20. Following the completion of the sale, the vice president now directly owns 41,323 shares of the company’s stock, valued at approximately $3,082,695.80. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 569,298 shares of company stock valued at $40,914,565. Insiders own 1.14% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

See Also: Why is momentum important to successful trading?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.